|Articles|November 15, 2002
Bent on Biologics: Attacking the Pathogenesis
Fledgling drugs like infliximab offer more hope than traditional methods
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement














